Cita APA

Dios Huerta, O. d., Ramírez-González, M. A., Gómez-Soria, I., Segura-Collar, B., Manosalva, J., Megías, D., . . . Sánchez-Gómez, P. (2024). NKG2C/ KLRC2 tumor cell expression enhances immunotherapeutic efficacy against glioblastoma.

Citación estilo Chicago

Dios Huerta, Olaya de, et al. NKG2C/ KLRC2 Tumor Cell Expression Enhances Immunotherapeutic Efficacy against Glioblastoma. 2024.

Cita MLA

Dios Huerta, Olaya de, et al. NKG2C/ KLRC2 Tumor Cell Expression Enhances Immunotherapeutic Efficacy against Glioblastoma. 2024.